Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

V Zanni

Showing results (31-40 of 147) with videos related to

Pageof 15
Sort By:
Journal of Acquired Immune Deficiency Syndromes (1999)|May 16, 2014
Increased arterial inflammation relates to high-risk coronary plaque morphology in HIV-infected patientsAhmed Tawakol, Janet Lo, Markella V Zanni, et al.
HIV Clinical Trials|March 10, 2017
Follow YOUR Heart: development of an evidence-based campaign empowering older women with HIV to participate in a large-scale cardiovascular disease prevention trialMarkella V Zanni, Kathleen Fitch, Corinne Rivard, et al.
AIDS (London, England)|December 24, 2015
Reduced ovarian reserve relates to monocyte activation and subclinical coronary atherosclerotic plaque in women with HIVSara E Looby, Kathleen V Fitch, Suman Srinivasa, et al.
Annals of the American Thoracic Society|June 29, 2022
Chronic Human Immunodeficiency Virus Infection Is Associated with Accelerated Decline of Forced Expiratory Volume in 1 Second among Women but Not among Men: A Longitudinal Cohort Study in UgandaJenna McNeill, Samson Okello, Ruth Sentongo, et al.
The Journal of Clinical Endocrinology and Metabolism|November 5, 2010
TNF-alpha antagonism with etanercept decreases glucose and increases the proportion of high molecular weight adiponectin in obese subjects with features of the metabolic syndromeTakara L Stanley, Markella V Zanni, Stine Johnsen, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|May 25, 2023
Brief Report: Use and Side Effects of Sodium-Glucose Transporter 2 Inhibitors Among US People With HIV With Clinical IndicationsMeghan E Sise, Nurit Katz-Agranov, Ian A Strohbehn, et al.
Communications Medicine|December 31, 2025
Molecular insights in HIV-associated cardiac dysfunctionMaría Valero-Muñoz, Eng Leng Saw, David R Pimentel, et al.
AIDS (London, England)|October 17, 2018
Relationship of visceral and subcutaneous adipose depots to markers of arterial injury and inflammation among individuals with HIVSuman Srinivasa, Kathleen V Fitch, Martin Torriani, et al.
Journal of the American College of Cardiology|January 7, 2017
HIV Infection and Heart Failure Outcomes in WomenSumbal A Janjua, Virginia A Triant, Daniel Addison, et al.
AIDS (London, England)|February 2, 2023
Sex modulates the association between inflammation and coronary atherosclerosis among older Ugandan adults with and without HIVSaate S Shakil, Tecla M Temu, Cissy Kityo, et al.
Pageof 15

Showing results (31-40 of 147) with videos related to

Sort By:
Pageof 15
Journal of Acquired Immune Deficiency Syndromes (1999)|May 16, 2014
Increased arterial inflammation relates to high-risk coronary plaque morphology in HIV-infected patientsAhmed Tawakol, Janet Lo, Markella V Zanni, et al.
HIV Clinical Trials|March 10, 2017
Follow YOUR Heart: development of an evidence-based campaign empowering older women with HIV to participate in a large-scale cardiovascular disease prevention trialMarkella V Zanni, Kathleen Fitch, Corinne Rivard, et al.
AIDS (London, England)|December 24, 2015
Reduced ovarian reserve relates to monocyte activation and subclinical coronary atherosclerotic plaque in women with HIVSara E Looby, Kathleen V Fitch, Suman Srinivasa, et al.
Annals of the American Thoracic Society|June 29, 2022
Chronic Human Immunodeficiency Virus Infection Is Associated with Accelerated Decline of Forced Expiratory Volume in 1 Second among Women but Not among Men: A Longitudinal Cohort Study in UgandaJenna McNeill, Samson Okello, Ruth Sentongo, et al.
The Journal of Clinical Endocrinology and Metabolism|November 5, 2010
TNF-alpha antagonism with etanercept decreases glucose and increases the proportion of high molecular weight adiponectin in obese subjects with features of the metabolic syndromeTakara L Stanley, Markella V Zanni, Stine Johnsen, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|May 25, 2023
Brief Report: Use and Side Effects of Sodium-Glucose Transporter 2 Inhibitors Among US People With HIV With Clinical IndicationsMeghan E Sise, Nurit Katz-Agranov, Ian A Strohbehn, et al.
Communications Medicine|December 31, 2025
Molecular insights in HIV-associated cardiac dysfunctionMaría Valero-Muñoz, Eng Leng Saw, David R Pimentel, et al.
AIDS (London, England)|October 17, 2018
Relationship of visceral and subcutaneous adipose depots to markers of arterial injury and inflammation among individuals with HIVSuman Srinivasa, Kathleen V Fitch, Martin Torriani, et al.
Journal of the American College of Cardiology|January 7, 2017
HIV Infection and Heart Failure Outcomes in WomenSumbal A Janjua, Virginia A Triant, Daniel Addison, et al.
AIDS (London, England)|February 2, 2023
Sex modulates the association between inflammation and coronary atherosclerosis among older Ugandan adults with and without HIVSaate S Shakil, Tecla M Temu, Cissy Kityo, et al.
Pageof 15